Preview

Problems of Particularly Dangerous Infections

Advanced search

Diagnostics of Human Middle-East Respiratory Syndrome

https://doi.org/10.21055/0370-1069-2014-4-56-60

Abstract

Middle-East respiratory syndrome is a human disease caused by a new coronavirus. In December, 2012 WHO published draft regulatory document on diagnostics of the virus. It was recommended to use two methods of disease diagnostics - two-phase reverse-transcription real-time PCR and enzyme immunoassay. The first phase of the PCR-diagnostics should include reverse-transcription real-time PCR targeted on the genome fragment upwards of upE. The second (control) PCR-test may be alternatively targeted within the bonds of the genome, its target being non-crisscross with upE gene. It should include sequencing of, at least, a segment of one of the viral genomes and comparative analysis of the obtained sequence along with the like ones deposited in the GenBank. Enzyme immunoassay is retrospectively used for virus-specific antibody detection in convalescents’ blood sera. Examined are the key specifications of the methods for the detection of ethiological agent or specific antibodies to it, and WHO methodological recommendations in case of Middle-East respiratory syndrome diagnostics.

About the Authors

L. F. Stovba
The 48th Central Research Institute of the Ministry of Defense
Russian Federation


V. N. Lebedev
The 48th Central Research Institute of the Ministry of Defense
Russian Federation


A. A. Petrov
The 48th Central Research Institute of the Ministry of Defense
Russian Federation


V. S. Kulish
The 48th Central Research Institute of the Ministry of Defense
Russian Federation


S. V. Borisevich
The 48th Central Research Institute of the Ministry of Defense
Russian Federation


References

1. Stovba L.F., Lebedev V.N., Petrov A.A., Kulish V.S., Borisevich S.V. [Middle-East respiratory syndrome – human diseases caused by a new coronavirus]. Voen. Med. Zh. 2013; 11:76–7.

2. Bermingham A., Heinen P., Iturriza-Gomara M., Gray J., Appleton H., Zambon M.C. Laboratory diagnosis of SARS. Philos. Trans. R. Soc. Lond. В. Biol. Sci. 2004; 359(1447):83–9.

3. Boheemen S., Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., Osterhaus A.D.M.E., Haagmans B.L., Gorbalenea A.E., Snijder E.J., Fouchier R.A.M. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012, 3(6):pii:e00473-12. (cited 20 Nov 2012). doi:10/1128/mBio.00473-12. Available from: http://mbio.asm.org/content/3/6/e00473-12.full.

4. Corman V.M., Müller M.A., Costabel U., Timm J., Binger T., Meyer B., Kreher P., Lattwein E., Eschbach-Bludau M., Nitsche A., Bleicker T., Landt O., Schweiger B., Drexler J.F., Osterhaus A.D., Haagmans B.L., Ditter U., Bonin F., Wolff T. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012; 17(49):pii=20334. (cited 06 Dec 2012). Available from: http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20334.

5. Corman V.M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., Boheemen S., Goral R., Ballhause M., Bestebroer T.M., Muth D., Muller M.A., Drexler J.F., Zambon M., Osterhaus A.D., FouchierR.M. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012; 17(39):pii=20285. (cited 27 Sep 2012). Available from: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=20285.

6. de Groot R.J., Baker S.C., Baric R., Enjuanes L., Gorbalenya A.E., Holmes K.V., Brown C.S., Drosten C., Fouchier R.A., Galiano M. Family Coronaviridae. In: Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses; King A.M.Q., Adams M.J., Carstens E.B., Lefkowitz E.J. (Eds.). Elsevier Academic Press: Amsterdam, The Netherlands, 2012. P. 806–28.

7. de Souza Luna L.K., Heiser V., Regamey N., Panning M., Drexler J.F., Mulangu S., Sims A.C., Tilton S.C., Menachery V.D., Gralinski L.E., Schafer A., Matzke M.M., Webb-Robertson B.J., Chang J. Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J. Clin. Microbiol. 2007; 45(3):1049–52.

8. Emery S.L., Erdman D.D., Bowen M.D., Newton B.R., Winchell J.M., Meyer R.F., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F. Real-time reverse transcription-polymerase chain reaction assay for SARSassociated coronavirus. Emerg. Infect. Dis. 2004; 10(2):311–16.

9. Khan G. A novel coronavirus capable of lethal human infections: an emerging picture. Virology Journal. 2013; 10:66. (cited 28 Feb 2013). doi:10.1186/1743-422X-10-66. Available from: http://www.virologyj.com/content/10/1/66.

10. Kindler E., Jonsdottir H.R., Muth D., Hamming O.J., Hartmann R., Rodriguez R., Geffers R., Fouchier R.A., Drosten C., Muller M.A., Dijkman R., Thiel R. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio. 2013; 4(1):e00611-12. (cited 19 Feb 2013). doi:10.1128/mbio.00611-12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573664/.

11. Li W., Shi Z., Yu M. Ren W., Smith C., Epstein J.H. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005; 310:676–9. (cited 29 Sep 2005). doi:10.1126/science.1118391. Available from: http://www.sciencemag.org/content/310/5748/676.

12. Masters P.S. The molecular biology of coronaviruses. Adv. Virus Res. 2006; 66:193–292.

13. Palm D., Pereyaslov D., Vaz J., Broberg E., Zeller H., Gross D., Brown C.S. Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe. Euro Surveill. 2012; 49(17):pii=20335. (cited 5 Dec 2012). Available from: http://www.eurosurveillance.org/images/dynamic/EE/V17N49/art20335.pdf

14. Pollak M.P., Pringle C., Madoff L.S., Memish Z.A. Novel coronavirus – Middle East. J. Infect. Dis. 2013; 17(2):е143-4. (cited 27 Dec 2012). doi: 10.1016/j.ijid.2012.12.001. Available from: http://www.ijidonline.com/article/S1201-9712%2812%2901310-0/fulltext

15. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment. Severe respiratory disease associated with a novel coronavirus. Stockholm: ECDC; 19 February 2013. (cited 22 Feb 2014). Available from: http://ecdc.europa.eu/en/ publications/Publications/novelcoronavirus-rapid-risk-assessment-update.pdf.

16. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J., Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early splitoff from the coronavirus group 2 lineage. J. Mol. Biol. 2003; 331:991–1004. 17. Vijgen L., Moës E., Keyaerts E., Li S., Van Ranst M. A pancoronavirus RT-PCR assay for detection of all known coronaviruses. Methods Mol. Biol. 2008; 454:3–12.

17. WHO. Global Alert and Response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV) – update. 07 Feb 2014 (cited 07 Feb 2014). Available from: http://www.who.int/csr/don/2014_02_07mers/en/index.html.

18. Zaki A.M., van Boheemen S., Bestebroer Т.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012; 367:1814–20.


Review

For citations:


Stovba L.F., Lebedev V.N., Petrov A.A., Kulish V.S., Borisevich S.V. Diagnostics of Human Middle-East Respiratory Syndrome. Problems of Particularly Dangerous Infections. 2014;(4):56-60. (In Russ.) https://doi.org/10.21055/0370-1069-2014-4-56-60

Views: 1069


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)